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Abstract
Background: T1 mapping enables assessment of myocardial characteristics. As the most common type of
arrhythmia, atrial fibrillation (AF) is often accompanied by a variety of cardiac pathologies, whereby the irregular
and usually rapid ventricle rate of AF may cause inaccurate T1 estimation due to mis-triggering and inadequate
magnetization recovery. We hypothesized that systolic T1 mapping with a heart-rate-dependent (HRD) pulse
sequence scheme may overcome this issue.
Methods: 30 patients with AF and 13 healthy volunteers were enrolled and underwent cardiovascular magnetic
resonance (CMR) at 3 T. CMR was repeated for 3 patients after electric cardioversion and for 2 volunteers after
lowering heart rate (HR). A Modified Look-Locker Inversion Recovery (MOLLI) sequence was acquired before
and 15 min after administration of 0.1 mmol/kg gadopentetate dimeglumine. For AF patients, both the fixed
5(3)3/4(1)3(1)2 and the HRD sampling scheme were performed at diastole and systole, respectively. The HRD
pulse sequence sampling scheme was 5(n)3/4(n)3(n)2, where n was determined by the heart rate to ensure
adequate magnetization recovery. Image quality of T1 maps was assessed. T1 times were measured in myocardium
and blood. Extracellular volume fraction (ECV) was calculated.
Results: In volunteers with repeated T1 mapping, the myocardial native T1 and ECV generated from the 1st
fixed sampling scheme were smaller than from the 1st HRD and 2nd fixed sampling scheme. In healthy
volunteers, the overall native T1 times and ECV of the left ventricle (LV) in diastolic T1 maps were greater than
in systolic T1 maps (P < 0.01, P < 0.05). In the 3 AF patients that had received electrical cardioversion therapy,
the myocardial native T1 times and ECV generated from the fixed sampling scheme were smaller than in the
1st and 2nd HRD sampling scheme (all P < 0.05). In patients with AF (HR: 88 ± 20 bpm, HR fluctuation: 12 ± 9 bpm),
more T1 maps with artifact were found in diastole than in systole (P < 0.01). The overall native T1 times and ECV of
the left ventricle (LV) in diastolic T1 maps were greater than systolic T1 maps, either with fixed or HRD sampling
scheme (all P < 0.05).
Conclusion: Systolic MOLLI T1 mapping with heart-rate-dependent pulse sequence scheme can improve image
quality and avoid T1 underestimation. It is feasible and with further validation may extend clinical applicability of
T1 mapping to patients with atrial fibrillation.
Keywords: T1 mapping, Modified Look-Locker inversion recovery, Extracellular volume fraction, Atrial fibrillation,
Cardiovascular magnetic resonance
* Correspondence: fanzm120@126.com
1Department of Radiology, Beijing Anzhen Hospital, Capital Medical
University, 100029 Beijing, China
Full list of author information is available at the end of the article
© 2016 Zhao et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Zhao et al. Journal of Cardiovascular Magnetic Resonance  (2016) 18:13 
DOI 10.1186/s12968-016-0232-7
Background
Atrial fibrillation (AF) is the most common clinical car-
diac arrhythmia. The mechanisms of AF are complex
and associated with structural and electrical remodeling
in the atrial and ventricular myocardium [1]. Develop-
ment of atrial fibrosis is the hallmark of structural re-
modeling in AF and considered the substrate for AF.
In contrast, data on ventricular fibrosis of patients
with AF are limited, although ventricular fibrosis has
a detrimental effect on both systolic and diastolic
function in patients with AF [2, 3]. Atrial and ven-
tricular fibrosis in AF is likely to share many com-
mon mechanisms, including excessive accumulation of
collagen either in regions of myocyte loss or diffusely
in areas of extracellular matrix in the interstitium [4].
T1 mapping and derived extracellular volume fraction
(ECV) enable quantitative assessment of myocardial
characteristics, such as edema, focal and diffuse fibro-
sis [5–7]. T1 mapping and ECV may provide useful
information for patients with AF. However, the ir-
regular and usually rapid ventricular rate hindered the
application of T1 mapping in patients with AF. Although
different T1 mapping methods such as saturation-
pulse-prepared heart-rate-independent inversion re-
covery T1 mapping have potential advantages in
arrhythmia [8], the Modified Look-Locker Inversion
Recovery (MOLLI) sequence is still widely used due
to its higher precision and better reproducibility [9, 10].
The heart rate sensitivity of MOLLI has been significantly
reduced by modification of sampling schemes (5(3)3
and 4(1)3(1)2 for pre-contrast and post-contrast T1
mapping, respectively) to the point where it is of
much less concern [11]. The largest factor that affects
the MOLLI heart rate sensitivity was the time be-
tween the inversions. It can be mitigated by increas-
ing the time between inversions [12]. But the exact
method how to increase the time between inversions
is not well established yet. In addition, at higher heart
rate, the time window with minimal motion in dia-
stole shortens more than in systole. In patients with
AF, although the R-R interval varies in each cardiac
cycle, the variation in systole is smaller than in dia-
stole [11]. It is potentially practicable to acquire T1
mapping in systole in patients with AF.
Therefore, we hypothesize that systolic T1 mapping
with heart-rate-dependent (HRD) pulse sequence sam-
pling scheme may be feasible in patients with AF. We
compared the differences of T1 times and ECV acquired
in systolic and diastolic phase with fixed/HRD pulse se-
quence sampling scheme, and assessed the accuracy of
systolic T1 mapping with HRD pulse sequence sampling
scheme in patients with AF who underwent cardiovascu-
lar magnetic resonance (CMR) twice, before and after
electric cardioversion.
Methods
The study was approved by Beijing Anzhen Hospital
ethics committee, and written informed consent was
obtained from all participants. A detailed explanation
concerning contrast agent was given to each participant.
Study population
Thirteen healthy volunteers and thirty patients with
“persistent” AF without contraindication to CMR were
recruited. None of the healthy volunteers was referred as
patient for clinical CMR which then turned out to be
normal, all of them had no evidence or risk factors of
cardiovascular disease. The AF patients were defined as
“persistent”, whose duration of continuous AF episodes
lasted > 7 days or required electrical cardioversion. Ex-
clusion criteria were presence of a permanent pace-
maker, severe claustrophobia, and severe impairment of
renal function (glomerular filtration rate < 30 mL/min/
1.73 m2).
HRD pulse sequence sampling scheme determination
In the MOLLI sequence with fixed sampling scheme,
such as 5(3)3 or 4(1)3(1), the inversion time between
data acquisition is fixed as 3 heartbeats or 1 heartbeat as
shown in the parentheses. At higher heart rate, each sin-
gle heartbeat duration is shorter than at slow heart rate.
Under such circumstances, the shorter inversion time
will lead to inadequate magnetization recovery before
acquiring the next data inversion episode, which results
in underestimation of T1 times. To ensure the full re-
covery of longitudinal magnetization before the follow-
ing inversion pulse is applied, the following pause in
units of heartbeats needs to be increased along with the
increase of the heart rate. Theoretically, after a duration
of 4 times of T1 time (the maximal T1 time expected for
the tissue of interest is approximately 2000 ms), the
magnetization of tissue is almost back to equilibrium.
For the 5(3)3 scheme, at heart rate of 60 beats per mi-
nute (bpm, RR interval = 1000 ms), it takes (5 + 3) ×
1000 = 8000 ms (which equals to 4 times of tissue of in-
terest’s T1 time) until the second inversion is played out.
At higher heart rate, using the above scheme may lead
to inadequate inversion recovery. It would make sense
to set up different sampling schemes that adapt to the
increased heart rate.
For the consideration of ensuring complete
magnetization recovery at higher heart rates, the sampling
schemes 5(3)3 and 4(1)3(1)2 were adopted to modify
the recovery to be determined by heart rate. Based on
the principle that 5(3)3 scheme is optimized for a
heart rate of 60 bpm (1000 ms), for the pre-contrast
T1 mapping, the heartbeat number of the second T1
inversion recovery is calculated as: n = (5+3)/(heart
rate in ms) × 1000-5; for the post-contrast T1 mapping,
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the heartbeat number of the inversion is calculated
as: n = (4+1)/(heart rate in ms) × 1000-4. We set up
sampling schemes for various heart rate ranges with
bpm increment of 5 from 50 to 150 bpm (Fig. 1a).
Study procedure
For the purpose of testing the feasibility and accuracy of
T1 mapping with the HRD pulse sequence sampling
scheme, two healthy volunteers in normal sinus rhythm
with relatively high heart rate (HR, volunteer 1: 67–
69 bpm, volunteer 2: 86–89 bpm) during first scan were
asked to undergo two CMRs before and after taking
beta-blockers. They underwent T1 mapping with fixed
and HRD sampling scheme at first scan, and at the next
day, after taking beta-blocker, they underwent the sec-
ond T1 mapping scan with fixed sampling scheme (HR
during scan: 57–59 bpm and 58–60 bpm, respectively).
The left-ventricle myocardial per-segment native T1
time and ECV generated from fixed sampling scheme at
first scan, HRD sampling scheme at first scan, and fixed
sampling scheme at second scan were compared.
For observing the impact of different cardiac phases
(systole and diastole) on T1 times, 11 healthy volunteers
in normal sinus rhythm (HR: 60 ± 5 bpm, HR fluctu-
ation: 3 ± 3 bpm) underwent T1 mapping with fixed
sampling scheme (5(3)3/4(1)3(1)2) at diastole and sys-
tole. The number of T1 maps and myocardial segments
with artifact generated from different cardiac phases
were recorded and compared; the T1 time and ECV gen-
erated from different cardiac phases were compared.
For verifying the feasibility of systolic T1 mapping with
HRD sampling scheme, patients with AF (HR: 88 ±
20 bpm, HR fluctuation: 12 ± 9 bpm) underwent T1
mapping with fixed and HRD sampling scheme at
diastole and systole. The number of T1 maps and
myocardial segments with artifact generated from differ-
ent sampling scheme and cardiac phases combination
were recorded and compared; the T1 time and ECV gen-
erated from different sampling scheme and cardiac
phases combination were compared.
For the purpose of verifying the accuracy and effective-
ness of systolic T1 mapping with the HRD pulse sequence
sampling scheme, three patients (with AF) who received
electric cardioversion, at the next day of cardioversion
underwent the second T1 mapping with HRD sampling
scheme in sinus rhythm, at diastole and systole. The left-
ventricle myocardial per-segment native T1 time and ECV
generated from different sampling schemes and cardiac
phases combination at first scan, and HRD sampling
scheme with different cardiac phases at second scan were
compared. The flow chart of study is showed in Fig. 1b.
CMR acquisition
All CMR was performed using a 3 T MR system
(MAGNETOM Verio, Siemens Healthcare, Erlangen,
Germany) with a 32-channel cardiac coil. Subject-
specific, volume-selective first- and second-order B0-
shimming based on field maps derived from double-
gradient-echo acquisitions was performed to improve
static field uniformity.
T1 mapping sequence was obtained using a Siemens
prototype (#448B, system software version syngo MR
B17A). Data were acquired in basal, mid-ventricular, and
apical short-axis planes at diastole and systole before and
15 min after administration of 0.1 mmol/kg gadopentetate
dimeglumine (Magnevist, Bayer Healthcare). The diastolic
phase was determined by the system with captured trigger
delay (TD) according to the ECG gating, the systolic phase
was set to TD of 0 ms (the acquisition started after
120 ms due to the TI start time) [13]. For the HRD
Fig. 1 Flow chart and heart-rate-dependent sampling scheme. a, the heart-rate-dependent sampling schemes for heart rate ranges with bpm
increment of 5 from 50 to 150 bpm; b, flow chart of study, first performed in healthy volunteers (left), then in patients with AF (right). HR = heart
rate; HRD = heart rate dependent; CMR = cardiovascular magnetic resonance
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sampling scheme, the number of inversions was deter-
mined by referencing the highest heart rate before the
actual scan. Imaging parameters were: TR = 2.6-
2.7 ms, TE = 1.0-1.1 ms, FA = 35°, FOV = (270 ×
360) mm2, matrix = 256 for heart rate < 90 bpm, 192
for heart rate > 90 bpm, slice thickness = 6 mm,
BW= 1045-1028Hz/px, GRAPPA acceleration factor 2,
linear phase-encoding ordering, minimum TI of 120 ms.
The quality control was performed during scanning by
reviewing the “goodness of fit” map and source images to
allow an immediate repetition of suboptimal measure-
ments to minimize the respiratory motion and off-
resonance effects. The blood sample was taken just before
CMR to measure hematocrit for ECV calculation.
For the purpose of clinical diagnosis, all patients
also received CMR protocols including cine and late
gadolinium enhancement (LGE) imaging as described
elsewhere [14].
Image analysis
All image datasets were transferred to a workstation
(Viewing and Argus, Siemens Healthcare, Erlangen,
Germany) for offline analysis. The T1 maps and source
images were assessed, myocardial segments with artifact
were excluded for further analysis. Two experienced
readers assessed artifacts in consensus. The heart rate of
each cardiac cycle during scanning of every image was
recorded, the variability in heart rate was calculated as
the standard deviation from the mean heart rate.
The left-ventricular (LV) myocardium was delineated
by manually contouring the endo-cardial and epi-cardial
borders. Care was taken to avoid contamination of signal
from blood or epi-cardial fat. T1 time of the blood was
measured by manually drawing a region of interest in
the LV cavity of T1* map (T1 map based on fitting without
Look-Locker correction) taking care to avoid the papillary
muscles. When artifact existed in certain segment in
image originated from any single diastole/systole and
fixed/HRD sampling scheme combination, the patient’s
same segment generated from T1 maps with other differ-
ent cardiac phase and sampling scheme combinations
were excluded for per-segment pairwise comparison. But
all of the assessable segments generated from any single
diastole/systole and fixed/HRD sampling scheme combin-
ation were included in calculating the respective average
overall LV myocardial T1 times. The overall LV myocar-
dial native T1 time was mean of T1 times of basal, mid-
ventricular and apical levels. For the participants with
repeated CMRs, all of the pre- and post-contrast per-
segment (according to American Heart Association myo-
cardial 17 segments classification, apical segment was ex-
cluded in this analysis) myocardial T1 times were drawn
in T1 maps generated from different cardiac phases and
sampling scheme combinations. ECV was calculated from
T1 maps acquired pre- and post-contrast calibrated by
blood hematocrit [15]. The ECV was calculated as:














Data are presented as mean and standard deviation. Dif-
ferences between means were tested by the paired t-test
and one-way analysis of variance as appropriate. The as-
sessable images and segments were compared between
systole and diastole using χ2 test. The overall LV myo-
cardial native T1 times and ECV generated from differ-
ent cardiac phases and sampling scheme combinations
were compared in all participants. The per-segment
myocardial native T1 times and ECV generated from dif-
ferent cardiac phases and sampling scheme combinations
were compared in participants with repeated CMRs. The
statistical significance was defined as p < 0.05. Statistical
analysis was performed using SPSS software (SPSS Inc.,
Chicago, IL, USA, version 17.0).
Results
The demographic data, heart rate and heart rate fluctu-
ation during scan, LV functional indices of healthy vol-
unteers and patients with AF are listed in Table 1.
Table 1 Demographic data and left-ventricle functional indices





Gender, female 3 (23.08 %) 10 (33.33 %)
Age (years) 53 ± 18 54 ± 13
Height (m) 1.70 ± 0.06 1.69 ± 0.09
Weight (kg) 76.35 ± 14.97 76.20 ± 15.21
BMI (kg/m2) 26.17 ± 3.87 26.46 ± 3.94
Average HR (bpm) 62 ± 9 88 ± 20
HR fluctuation (bpm) 3 ± 3 12 ± 9
Left atrium volume (cm3) 139.03 ± 45.05 158.42 ± 50.55
EF (%) 63.17 ± 7.00 49.19 ± 11.83
EDV (ml) 98.17 ± 19.96 87.81 ± 26.85
ESV (ml) 36.46 ± 10.96 44.94 ± 19.51
SV (ml) 61.71 ± 13.13 42.89 ± 16.61
MM (g) 86.12 ± 24.59 85.94 ± 25.01
CO (l/min) 3.97 ± 1.17 3.58 ± 1.10
LGE positive subject 0 10
Data were presented in mean ± standard deviation. AF atrial fibrillation,
BMI body mass index, HR heart rate, EF ejection fraction, EDV end-diastolic
volume, ESV end-systolic volume, SV stroke volume, MM left-ventricle myocardial
mass, CO cardiac output, LGE late gadolinium enhancement
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Comparison between HRD and fixed sampling scheme in
normal sinus rhythm with high heart rate
For the two healthy volunteers that underwent two
CMRs, volunteer 1 presented HR of 67–69 bpm during
the first scan, the HRD sampling scheme was 5(4)3/
4(2)3(2)2, volunteer 2 presented a HR of 86–89 bpm
during the first scan with HRD sampling scheme of
5(7)3/4(3)3(3)2. In volunteer 1, there were no significant
differences of per-segment myocardial native T1 times
and ECV among 1st 5(3)3/4(1)3(1)2, 1st 5(4)3/4(2)3(2)2
and 2nd 5(3)3/4(1)3(1)2 either in diastolic or systolic T1
maps (all p > 0.05). In volunteer 2, there were significant
differences of per-segment myocardial native T1 times
and ECV between 1st 5(3)3/4(1)3(1)2 and 1st 5(7)3/
4(3)3(3)2, and between 1st 5(3)3/4(1)3(1)2 and 2nd 5(3)3/
4(1)3(1)2 either in diastolic or systolic T1 mappings (all
p < 0.05); but no significant differences of per-segment
myocardial native T1 times and ECV between 1st 5(7)3/
4(3)3(3)2 and 2nd 5(3)3/4(1)3(1)2 either in diastolic or
systolic T1 mappings (all p > 0.05).
Comparison between systole and diastole T1 mapping in
healthy volunteers
In the 11 healthy volunteers, there were 66 myocardial
native T1 maps and 66 myocardial post-contrast T1
maps (11 volunteers × 3 slices × 2 (1 of diastole and 1 of
systole)). 6 segments in 2 native T1 maps and 7 seg-
ments in 3 post-contrast T1 maps were excluded due to
the presence of artifacts. In the native T1 maps with arti-
facts, 4 segments of 1 T1 map were diastolic images; in
the post-contrast T1 maps with artifacts, 5 segments of
2 T1 maps were diastolic images. There were no signifi-
cant differences of assessable images between systole
and diastole (χ2 = 0.204, p > 0.05).
The LV overall native T1 times, post-contrast T1 times
and ECV of myocardium, pre-/post-contrast blood T1
times of diastolic and systolic T1 mapping were com-
pared and are presented in Table 2. There were minor
but statistically significant differences in myocardial and
blood T1 times and ECV between diastolic and systolic
T1 maps.
Comparison among different HRD/fixed sampling
schemes and systole/diastole combination T1 mapping in
patients with AF
For the 30 patients with “persistent” AF, there were 378
native T1 maps and 378 post-contrast T1 maps (27
patients × 3 slices × 4 (diastole/systole + fixed/HRD
sampling scheme combination) + 3 patients × 3 slices ×
6 (1st CMR: diastole/systole + fixed/HRD sampling
scheme combination = 4; 2nd CMR: diastole/systole +
HRD sampling scheme combination = 2)). 599 segments
in 113 native T1 maps and 592 segments in 111 post-
contrast T1 maps were excluded due to the presence of
artifacts. The artifacts we encountered mainly were off
resonance related dark banding artifact and mistrigger
related motion artifact (Fig. 2). The dark banding artifact
were presented evenly in diastolic and systolic images,
although the local shimming were applied and different
center frequencies were tried, 35 segments (0.99 %) were
with identified banding artifact ultimately. The mistrig-
ger related motion artifacts were more commonly found
in diastolic images than systolic images. In the native T1
maps with motion artifacts, 542 segments (15.36 %) of
100 T1 maps (13.23 %) were diastolic images; in the
post-contrast T1 maps with artifacts, 531 segments
(15.05 %) of 97 T1 maps (12.83 %) were diastolic images.
Overall, there were more assessable T1 maps in systole
than diastole with significant differences (χ2 = 201.003,
p < 0.01). Most motion artifacts were presented in pa-
tients with moderately rapid heart rate and/or with se-
vere heart rate fluctuation (Fig. 3). In very rapid heart
rate (e.g. 130 bpm), the system default diastolic TD was
close to the systolic TD of 0 ms, therefore we obtained
two series of similar “systolic” T1 maps. Consequently,
very fast heart rate was observed with relatively less num-
ber of inferior quality images compared to moderate rapid
heart rate in diastolic T1 maps (Fig. 4).
The myocardial native T1 times and ECV generated
from HRD sampling scheme T1 maps were greater than
fixed sampling scheme T1 maps either in diastolic or
systolic phase with statistical significance (all p < 0.05).
The myocardial native T1 times generated from diastolic
T1 maps were longer than systolic T1 maps either in
fixed or in HRD scheme T1 maps with statistical sig-
nificance (all p < 0.05), the ECV generated from dia-
stole was larger than in systole, either in fixed or
HRD sampling scheme without statistical significance
(all p > 0.05). In the pre-contrast LV blood T1* maps,
blood T1 times generated from diastolic phase were
longer than systolic phase, while in the post-contrast
LV blood T1* maps, the blood T1 times from diastolic
Table 2 Comparison of pre-/post-contrast myocardium and
blood T1 times and ECV between diastolic and systolic T1 maps
in healthy volunteers
Diastole Systole P value
Overall LV myocardium
native T1 times (ms)
1247.73 ± 31.86 1231.06 ± 31.45 <0.01
Overall LV myocardium
post-contrast T1 times (ms)
544.94 ± 52.80 563.80 ± 56.89 <0.01
Overall LV pre-contrast
blood T1 times (ms)
1832.76 ± 61.76 1784.49 ± 82.02 <0.05
Overall LV post-contrast
blood T1 times (ms)
352.87 ± 49.15 365.53 ± 51.70 <0.01
Overall LV ECV (%) 25.11 ± 1.63 24.60 ± 1.58 =0.047
Data are presented in mean ± standard deviation. LV left ventricle,
ECV extracellular volume
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phase were shorter than systolic phase. Regarding the
comparison between fixed and HRD scheme, blood T1
times generated from fixed scheme were longer than HRD
scheme in pre-contrast; In post-contrast CMR, the blood
T1 from fixed scheme were shorter than HRD scheme
(nearly half of these differences were statistical significant).
The LV overall native T1 times, post-contrast T1 times
and ECV of myocardium, pre-/post-contrast blood T1
times generated from different diastolic/systolic and fixed/
HRD scheme combination were compared and are shown
in Table 3.
Three patients underwent CMR 2 times, before and
after electric cardioversion. Patient 1’s heart rate dur-
ing 1st CMR ranged 69–116 bpm, HRD scheme was
5(11)3/4(6)3(6)2; after electric cardioversion, the pa-
tient’s heart rate during 2nd CMR ranged 77–80 bpm,
scheme was 5(5)3/4(2)3(2)2. Patient 2’s heart rate dur-
ing 1st CMR ranged 64–87 bpm, HRD scheme was
5(7)3/4(3)3(3)2; the patient’s heart rate during 2nd
CMR ranged 62–65 bpm, scheme was 5(4)3/4(1)3(1)2.
Patient 3’s heart rate during 1st CMR ranged 80–
101 bpm, HRD was 5(9)3/4(5)3(5)2; the patient’s heart
Fig. 2 Artifacts of T1 mapping images. Upper line are the example images output by T1 mapping illustrate the off resonance related dark
banding artifact, the line-like artifact at anterior segment are presented in every source image and color map; lower line are the example of
mistrigger related motion artifact, all images except the 2nd and 5th image (green arrow) were acquired at diastolic phase, the inconsistent
contour of the source images lead to the blur appearance of the final color map
Fig. 3 Comparison of diastolic and systolic T1 mapping images in patients with AF. Example images output by T1 mapping in patients with AF.
a-b: a AF patient with heart rate ranged from 54 to 74 bpm during scan. a presented the motion corrected IR images acquired at system default
diastolic trigger delay, the second image (as shown in the green box) was mistriggered at systolic phase; b presented the motion corrected IR
images acquired at systolic phase, the images are in consistent contour. c-d: a AF patient with heart rate ranged from 72 to 112 bpm. c presented the
motion corrected IR images acquired at system default diastolic phase, the 7th and 8th images (marked with green box) were mistriggered at systolic
phase; d presented the motion corrected IR images acquired at systolic phase, no mistriggered images was found
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rate during 2nd CMR ranged 75–77 bpm, scheme was
5(5)3/4(2)3(2)2. For all the 3 patients, either in the
diastolic or systolic T1 maps, there were significant
differences of per-segment native T1 times and ECV
between 1st CMR fixed scheme and HRD scheme,
and between 1st CMR fixed scheme and 2nd CMR
HRD scheme (all p <0.01), but no significant differ-
ences of per-segment native T1 times and ECV be-
tween 1st CMR HRD scheme and 2nd CMR HRD
scheme (p >0.05, Table 4).
Fig. 4 Numbers of myocardial diastolic native T1 maps with artifacts. Vertical axis stands for the numbers of diastolic native T1 maps with
artifacts, horizontal axis stands for the presented highest heart rate during scan, below are the patient numbers at different heart rate levels
Table 3 Comparison of pre-/post-contrast myocardium and blood T1 times and ECV between different diastolic/systolic and fixed/
HRD scheme T1 maps in patients with persistent AF









Overall LV myocardium native
T1 times (ms)
1272.76 ± 39.30 1263.29 ± 40.71 1311.00 ± 44.51 1304.83 ± 52.01 1 vs. 2: <0.01
3 vs. 4: <0.05
1 vs. 3: <0.01
2 vs. 4: <0.01
Overall LV myocardium post-contrast
T1 times (ms)
543.42 ± 57.04 551.07 ± 57.49 571.37 ± 66.16 588.94 ± 64.31 1 vs. 2: <0.05
3 vs. 4: >0.05
1 vs. 3: >0.05
2 vs. 4: <0.05
Overall LV pre-contrast blood
T1 times (ms)
1819.40 ± 136.03 1797.49 ± 132.23 1796.32 ± 132.02 1766.30 ± 133.51 1 vs. 2: >0.05
3 vs. 4: >0.05
1 vs. 3: >0.05
2 vs. 4: >0.05
Overall LV post-contrast blood
T1 times (ms)
359.61 ± 53.34 366.06 ± 52.73 393.03 ± 61.73 400.18 ± 64.13 1 vs. 2: <0.01
3 vs. 4: >0.05
1 vs. 3: <0.05
2 vs. 4: <0.05
Overall LV ECV (%) 26.70 ± 2.45 26.41 ± 2.73 28.02 ± 3.48 27.18 ± 3.36 1 vs. 2: >0.05
3 vs. 4: >0.05
1 vs. 3: <0.05
2 vs. 4: <0.05
Data are presented in mean ± standard deviation. ECV extracellular volume, HRD heart-rate-dependent, AF atrial fibrillation, LV left ventricle
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Discussion
The main findings of this study include: the HRD sam-
pling scheme can avoid the underestimation of T1 times
in the setting of rapid ventricle rate either in sinus
rhythm or arrhythmia; although the native T1 times/
ECV of myocardium in diastole are greater than in
systole, to obtain data at systole can improve the
image quality by decreasing the chance of mistrigger-
ing in patients with AF. Finally, a subset of patients
with repeated T1 mapping demonstrated the effective-
ness of systolic HRD sampling scheme in patients
with AF. In addition, to the best of our knowledge,
this is the first study using native T1 and ECV asses-
sing LV myocardium in patients with AF before cath-
eter ablation. Compared to healthy volunteers, the
patients with AF showed greater native T1 times and
ECV, which may be an indicator for myocardial fibro-
sis. Our findings are in line with other studies using
other methods or animal study [16, 17].
Validation of T1 mapping in HRD sampling scheme
Incomplete inversion recovery may lead to an underesti-
mation of T1 times. In patients with higher heart rate,
the R-R interval shortened, and the fixed sampling
scheme of 5(3)3/4(1)3(1)2 does not provide enough time
for the magnetization to get back to the equilibrium. In-
creasing the number of heartbeats after T1 inversion
recovery can avoid underestimation of T1 times. In our
study, we tested the feasibility and accuracy of HRD
sampling scheme in healthy volunteers and patients with
AF with repeated CMRs. In volunteers and patients with
AF, the T1 times and ECV generated from fixed sam-
pling scheme were smaller than HRD sampling scheme,
and repeated T1 mapping demonstrated that the HRD
sampling scheme can more accurately estimate the T1
times than the fixed sampling scheme. In volunteer 1,
the heartbeats number of T1 inversion recovery in-
creased in a small range (pre-contrast: 3 to 4, post-
contrast: 1 to 2), although the myocardial native T1
times and ECV generated from 1st fixed sampling
scheme were smaller than 1st HRD and 2nd fixed sam-
pling scheme, the differences did not reach statistical
significance. Volunteer 2’s heartbeats number of T1 in-
version recovery increased in a larger range (3 to 7 and
1 to 3), the differences of myocardial native T1 times
and ECV between 1st fixed sampling scheme and 1st
HRD/2nd CMR fixed sampling scheme reached statistical
significance. In the 3 patients with AF, all the heart-
beats number of T1 inversion recovery increased with
a large range (3 to 11, 7, 9 in the pre-contrast, and 1
to 6, 3, 5 in the post-contrast respectively). The myo-
cardial native T1 times and ECV of 1st fixed sampling
scheme were smaller than 1st and 2nd HRD sampling
scheme with statistical significance. The impact of the
HRD sampling scheme was more prominent for
higher heart rates. Thereby, HRD sampling scheme is
practical for rapid ventricle rate either in sinus rhythm or
arrhythmia.
Impact of cardiac cycle on T1 mapping
In healthy volunteers and patients with AF, both for
fixed and HRD sampling scheme, the myocardial native
T1 times and ECV in diastole were greater than in sys-
tole. Our findings concur in general with some previous
studies [13, 18, 19]. The differences of myocardial T1
times between diastole and systole can be explained
by partial-volume effect on diastole [13] and/or re-
duced intra-myocardial blood volume contamination
Table 4 Comparison of per-segment native T1 times and ECV in patients before/after electric cardioversion
Patient 1 Patient 2 Patient 3
P value P value P value
Diastole A: fixed Native T1 (ms) 1294.67 ± 16.50 A vs. B: <0.01 1233.83 ± 25.09 A vs. B: <0.05 1268.80 ± 34.85 A vs. B: <0.01
B: 1st HRD Native T1 (ms) 1353.30 ± 36.55 B vs. C: >0.05 1241.17 ± 16.08 B vs. C: >0.05 1289.57 ± 13.29 B vs. C: >0.05
C: 2nd HRD Native T1 (ms) 1342.60 ± 18.12 A vs. C: <0.01 1245.07 ± 11.98 A vs. C: <0.05 1289.07 ± 16.05 A vs. C: <0.01
A: fixed ECV (%) 23.12 ± 0.22 A vs. B: <0.01 22.28 ± 1.00 A vs. B: <0.01 27.25 ± 0.34 A vs. B: <0.01
B: 1st HRD ECV (%) 25.51 ± 0.88 B vs. C: >0.05 24.96 ± 0.24 B vs. C: >0.05 28.49 ± 0.37 B vs. C: >0.05
C: 2nd HRD ECV (%) 25.47 ± 1.14 A vs. C: <0.01 25.60 ± 0.97 A vs. C: <0.01 28.50 ± 0.21 A vs. C: <0.01
Systole A: fixed Native T1 (ms) 1283.30 ± 34.76 A vs. B: <0.01 1209.90 ± 33.24 A vs. B: <0.01 1249.73 ± 39.49 A vs. B: <0.01
B: 1st HRD Native T1 (ms) 1345.1 ± 23.40 B vs. C: >0.05 1246.37 ± 33.92 B vs. C: >0.05 1274.70 ± 17.68 B vs. C: >0.05
C: 2nd HRD Native T1 (ms) 1339.57 ± 25.75 A vs. C: <0.01 1250.80 ± 36.09 A vs. C: <0.01 1256.10 ± 17.91 A vs. C: <0.05
A: fixed ECV (%) 23.57 ± 0.62 A vs. B: <0.05 22.86 ± 2.58 A vs. B: <0.05 27.01 ± 1.50 A vs. B: <0.05
B: 1st HRD ECV (%) 24.41 ± 1.74 B vs. C: >0.05 23.74 ± 0.56 B vs. C: >0.05 27.13 ± 0.65 B vs. C: >0.05
C: 2nd HRD ECV (%) 24.76 ± 0.52 A vs. C: <0.05 23.56 ± 1.21 A vs. C: <0.05 27.14 ± 0.90 A vs. C: <0.05
Data are presented in mean ± standard deviation. ECV extracellular volume, HRD heart-rate-dependent
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in systole [18]. Nevertheless, the mean differences of
native T1 times (healthy volunteer: 16.67 ms; patients
with AF: 9.47 ms with fixed scheme and 6.17 ms with
HRD scheme) and ECV (healthy volunteer: 0.51 %;
patients with AF: 0.29 % with fixed scheme and
0.84 % with HRD scheme) were small and might not
be clinically relevant on an individual basis. Even so,
it is recommended to obtain and compare T1 maps
in the same cardiac phase to avoid potential bias [5].
Although apparent myocardial native T1 times and
ECV in systole were smaller than in diastole, more im-
ages in systole were evaluable than in diastole. In line
with other studies [13, 18, 20], our results revealed that
T1 mapping acquisition in systole increases the number
of evaluable images and segments both in healthy volun-
teers and patients with AF. At higher heart rates, the
motion-free time in diastole shortens more than in sys-
tole. In patients with AF, although the R-R interval varies
in each cardiac cycle, the variation in systole is smaller
than in diastole [11, 13] (Fig. 2). Therefore, the acquisi-
tion in systole resulted in more evaluable images. But in
case of lower ventricular rate, at mid to end diastole,
cardiac motion is relatively minor, and even in patients
with AF and low heart rates, diastolic images were
presented with less artifacts [13] (Fig. 3).
Diffuse ventricular fibrosis in patients with AF
Except the main finding of our study, our results also re-
vealed that the myocardial native T1 times and ECV of
patients with AF were greater than in healthy volunteers.
The cardiac profibrotic microenvironment in AF is un-
likely to be strictly limited to the atria, and the ventricu-
lar myocardium is also likely to be affected, ventricular
fibrotic changes are more pronounced in AF patients
than in subjects with sinus rhythm [1]. Although the ef-
fect of ventricular fibrosis in the pathogenesis of AF is
controversial, recent study found that diffuse ventricular
fibrosis is an independently predictor of AF recurrence
after ablation therapy [3]. T1 mapping and ECV allow
quantitative assessment of diffuse myocardial character-
istics fibrosis, which was only possible with biopsy in the
past. Ling et al. demonstrated diffuse ventricular fibrosis
in AF by employing post-contrast T1 mapping [2]. Fur-
thermore, our study demonstrated diffuse ventricular fi-
brosis in AF using the reliable parameter of ECV. This
technique provides a new method for investigating the
implication of ventricular fibrosis in AF.
Limitations
The number of participants included in this study is
relatively small, especially the number of participants
who underwent the CMR twice. Since the repeated
CMRs can test the efficiency of the HRD sampling
scheme, more participants need to be enrolled in a
future study. The HRD sequence used in this study is
relatively old version, the inversion time is expressed as
heartbeat, now a more advanced sequence with seconds
as unit is widely accepted by T1 mapping research com-
munity. Due to the sequence version’s limitations, we
are not able to test this sequence in our study. However,
it’s suggested that we utilize this advanced version of se-
quence in our future study. The operation of the HRD
sampling scheme is relatively complicated, and the im-
pact of HRD sampling scheme is more prominent in
higher heart rate, therefore further investigation is
needed to simplify the operation under the condition of
keeping the feature of HRD sampling scheme. Finally,
we did not perform the intra- and inter-observer vari-
ability, although a good agreement of intra- and inter-
observer variability has been demonstrated by other
studies [13, 20].
Conclusions
The heart-rate-dependent sampling scheme is helpful for
avoiding underestimation of T1 times, especially in sub-
jects with higher heart rates. Systolic T1 mapping yields
shorter myocardial native T1 times and ECV, but the
mean differences were small and, importantly, with the
benefit of improvement in data quality in subjects with
irregular and rapid heart rate. Together with these
findings, systolic MOLLI T1 mapping with a heart-rate-
dependent sampling scheme is feasible and its clinical
application can be extended to patients with atrial
fibrillation.
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